Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 9 - 21 |
| Updated: | 1/20/2018 |
| Start Date: | January 2016 |
| End Date: | September 2018 |
| Contact: | Natalie J Nokoff, MD |
| Email: | Natalie.Nokoff@childrenscolorado.org |
| Phone: | 720-777-3607 |
This study plans to learn more about puberty blockers and cross (testosterone and estradiol).
There is not much known about how these medications affect hormone levels, heart health and
overall general health in young transgender individuals.
There is not much known about how these medications affect hormone levels, heart health and
overall general health in young transgender individuals.
This study plans to learn more about puberty blockers and cross (testosterone and estradiol).
There is not much known about how these medications affect hormone levels, heart health and
overall general health in young transgender individuals.
There is not much known about how these medications affect hormone levels, heart health and
overall general health in young transgender individuals.
Inclusion Criteria:
- Followed in Endocrinology Clinic or Adolescent Medicine Clinic at Children's Hospital
Colorado
- Between age 9 and 21 years (inclusive)
- Identifies as transgender
- Has been on pubertal blockade or cross-sex hormones for at least three months.
Exclusion Criteria:
- Known diabetes
- Presence of significant medical or psychiatric comorbidities
- Using hormones not prescribed by a physician
We found this trial at
1
site
13123 E 16th Ave
Aurora, Colorado 80045
Aurora, Colorado 80045
(720) 777-1234
Phone: 720-777-3607
Children's Hospital Colorado At Children's Hospital Colorado, we see more, treat more and heal more...
Click here to add this to my saved trials
